GSK plc
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| GSK.L | MRK | GILD | SNY | PFE | AZN | |
|---|---|---|---|---|---|---|
| Market cap | 74.63B | 360.08B | 193.67B | 97.31B | 168.60B | 256.54B |
| P/E (TTM) | 15.8 | 115.8 | — | 21.4 | 38.9 | 23.8 |
| Forward P/E | 9.8 | 15.7 | 15.7 | 7.7 | 10.2 | 14.6 |
| Price/book | 4.2 | 8.6 | 16.4 | 1.3 | 2.0 | 5.1 |
| Dividend yield | 3.74% | 2.33% | 2.10% | 5.96% | 5.81% | 1.94% |
| 1-year change | +14.98% | +69.08% | +26.87% | −18.34% | +19.81% | −1.39% |
| Today | −0.32% | +0.52% | −0.75% | +0.79% | +0.48% | −0.76% |
The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.
Latest news
All GSK.L news ›Is GSK cutting jobs to fund R&D?
GSK is pressing ahead with a major global restructuring plan worth $2.5 billion, aimed at redirecting resources into late stage research and development. As part of this three year programme, the company is reducing more than 1,200 jobs…
Strikes at GSK’s Belgian sites over plans to cut 1200 jobs
Chemistry World Strikes at GSK’s Belgian sites over plans to cut 1200 jobs Employees strike outside GSK’s vaccine division headquarters and manufacturing plant in Wavre, Belgium, over plans to cut 1200 jobs Up to 1200 GSK employees in…
GSK showcases pipeline momentum across lung, gynaecological and gastrointestinal cancers at ESMO 2026
Switch to dark mode to head towards a more sustainable world together. More info For investors and media only First global Ris-Rez data to show positive anti-tumour activity in relapsed extensive-stage small-cell lung cancer AZUR-1 data to…
GSK plans to cut up to 1,217 jobs in Belgium as it begins three-year restructuring plan
BRUSSELS (Oct 15): GSK said on Wednesday it could cut as many as 1,217 jobs in Belgium, in the first sign that the British drugmaker's three-year plan to save £1.9 billion ($2.50 billion) in costs is moving into action. CEO Luke Miels had…
GSK: Maintaining Strong Buy For LAI HIV Sales Growth And Further Oncology Expansion
GSK plc stock update: oncology pipeline momentum (Mo‑Rez phase 1), Cabenuva HIV data, Q2 results and 2026 phase 3 plans—click for this GSK update. - GSK plc demonstrates strong oncology pipeline momentum, highlighted by Mo-Rez's phase 1…
Greater Philadelphia Life Sciences News: Agilent’s Philly Acquisition, GSK’s Big Bet & More
Leadership followed the same pattern. A Plymouth Meeting rare disease company named its next CEO from its own boardroom. Minaris Advanced Testing promoted Athenesia Faggins to lead quality and compliance after a career built across the…
GSK Korea Marks 40th Anniversary With Community Health Programs
Health Calendar Created With Older Adults Green Space Project Along Seoul's Jungnangcheon Stream Activities to Continue Through Year-End GSK Korea is running a series of community programs to promote local health, including the creation of…
GSK plc : UBS remains Neutral
Published on 10/15/2026 at 07:28 am EDT Berenberg still a buyer of GSK, considering stock undervalued October 14, 2026 at 10:33 am EDT GSK plc: Priced for the storm, being built for thereafter GSK: shareholders urge company to step up…
GSK expanding operations in Montgomery County
Home » News » GSK expanding operations in Montgomery County GSK, a U.K.-based biopharma company with its U.S. headquarters in Philadelphia, recently announced it will invest more than $800 million to expand its Montgomery County…
GSK plans more than 1,200 job cuts in Belgium
(GSK:NYSE) Seeking Alpha GSK (GSK) plans to cut up to 1,217 jobs in Belgium as part of a proposed restructuring affecting research and development, production, and international support services, according to multiple Belgian media…
From articles in the 4Search news index.
In the news
People in the coverage
Themes
Most coverage from
-
marketscreener.com26
-
themarketsdaily.com11
-
tradingview.com6
-
seekingalpha.com5
-
stocktitan.net5
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.